| Michael P Nogalski, MD | |
|
1050 Old Des Peres Rd., Suite 100, St. Louis, MO 63131-1865 | |
| (314) 569-0612 | |
| (314) 966-0664 |
| Full Name | Michael P Nogalski |
|---|---|
| Gender | Male |
| Speciality | Orthopedic Surgery |
| Experience | 37 Years |
| Location | 1050 Old Des Peres Rd., St. Louis, Missouri |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1326049636 | NPI | - | NPPES |
| 4319113 | Other | MO | AETNA |
| 18526 | Other | MO | ANTHEM |
| 200044043 | Other | MO | MEDICARE RAILROAD |
| 122984 | Other | MO | COVENTRY |
| 0900139 | Other | MO | UNITED HEALTHCARE |
| 212913 | Other | MO | HEALTHLINK |
| 30495443 | Other | MO | CIGNA |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207X00000X | Orthopaedic Surgery | 103285 (Missouri) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Orthopedic Associates, Llc | 7113995333 | 15 |
News Archive
Two NJIT biomedical researchers have received the prestigious Coulter Foundation Translational Awards for promising patent applications that may some day extend peoples' lives.The Coulter program provides funding for professors in established biomedical engineering departments within the U.S. Initial funding for each professor will be at least $200,000 over a two-year period.
In this post in the Guardian's "The Observer," Mark Honigsbaum, a research associate at the University of Zurich's Institute for Medical History, interviews Peter Seeberger, the director of the Max Planck Institute of Colloids and Interfaces in Potsdam, Germany, about a recent announcement that Seeberger and colleague François Lévesque "have discovered a simple and cost-effective way of synthesizing artemisinin from the waste products of the" sweet wormwood plant from which it is extracted.
Spectrum Pharmaceuticals, a biotechnology company with fully integrated commercial and drug development operations with a primary focus in hematology and oncology, today announced initiation of patient enrollment in the second part of the Company's randomized Phase 2 clinical program of ozarelix, a luteinizing hormone-releasing hormone (LHRH) antagonist, in men with prostate cancer for whom hormonal treatment is indicated.
Wednesday on The Diane Rehm Show, Kaiser Health News staff writer Mary Agnes Carey joined The Washington Post's Alec MacGillis and Health Affairs' Susan Dentzer to talk about the impact the recently passed health overhaul law will have on a variety of consumers, ranging from young people to senior citizens as well as employers, the uninsured and people with pre-existing conditions (NPR, 5/5).
They may be in small towns. They may only have a couple of surgeons. But for common operations, they may be safer and less expensive than their larger cousins, a new study finds.
› Verified 4 days ago
| Entity Name | Orthopedic Associates, Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1720159775 PECOS PAC ID: 7113995333 Enrollment ID: O20040924000034 |
News Archive
Two NJIT biomedical researchers have received the prestigious Coulter Foundation Translational Awards for promising patent applications that may some day extend peoples' lives.The Coulter program provides funding for professors in established biomedical engineering departments within the U.S. Initial funding for each professor will be at least $200,000 over a two-year period.
In this post in the Guardian's "The Observer," Mark Honigsbaum, a research associate at the University of Zurich's Institute for Medical History, interviews Peter Seeberger, the director of the Max Planck Institute of Colloids and Interfaces in Potsdam, Germany, about a recent announcement that Seeberger and colleague François Lévesque "have discovered a simple and cost-effective way of synthesizing artemisinin from the waste products of the" sweet wormwood plant from which it is extracted.
Spectrum Pharmaceuticals, a biotechnology company with fully integrated commercial and drug development operations with a primary focus in hematology and oncology, today announced initiation of patient enrollment in the second part of the Company's randomized Phase 2 clinical program of ozarelix, a luteinizing hormone-releasing hormone (LHRH) antagonist, in men with prostate cancer for whom hormonal treatment is indicated.
Wednesday on The Diane Rehm Show, Kaiser Health News staff writer Mary Agnes Carey joined The Washington Post's Alec MacGillis and Health Affairs' Susan Dentzer to talk about the impact the recently passed health overhaul law will have on a variety of consumers, ranging from young people to senior citizens as well as employers, the uninsured and people with pre-existing conditions (NPR, 5/5).
They may be in small towns. They may only have a couple of surgeons. But for common operations, they may be safer and less expensive than their larger cousins, a new study finds.
› Verified 4 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Michael P Nogalski, MD 1050 Old Des Peres Rd., Suite 100, St. Louis, MO 63131-1865 Ph: (314) 569-0612 | Michael P Nogalski, MD 1050 Old Des Peres Rd., Suite 100, St. Louis, MO 63131-1865 Ph: (314) 569-0612 |
News Archive
Two NJIT biomedical researchers have received the prestigious Coulter Foundation Translational Awards for promising patent applications that may some day extend peoples' lives.The Coulter program provides funding for professors in established biomedical engineering departments within the U.S. Initial funding for each professor will be at least $200,000 over a two-year period.
In this post in the Guardian's "The Observer," Mark Honigsbaum, a research associate at the University of Zurich's Institute for Medical History, interviews Peter Seeberger, the director of the Max Planck Institute of Colloids and Interfaces in Potsdam, Germany, about a recent announcement that Seeberger and colleague François Lévesque "have discovered a simple and cost-effective way of synthesizing artemisinin from the waste products of the" sweet wormwood plant from which it is extracted.
Spectrum Pharmaceuticals, a biotechnology company with fully integrated commercial and drug development operations with a primary focus in hematology and oncology, today announced initiation of patient enrollment in the second part of the Company's randomized Phase 2 clinical program of ozarelix, a luteinizing hormone-releasing hormone (LHRH) antagonist, in men with prostate cancer for whom hormonal treatment is indicated.
Wednesday on The Diane Rehm Show, Kaiser Health News staff writer Mary Agnes Carey joined The Washington Post's Alec MacGillis and Health Affairs' Susan Dentzer to talk about the impact the recently passed health overhaul law will have on a variety of consumers, ranging from young people to senior citizens as well as employers, the uninsured and people with pre-existing conditions (NPR, 5/5).
They may be in small towns. They may only have a couple of surgeons. But for common operations, they may be safer and less expensive than their larger cousins, a new study finds.
› Verified 4 days ago
Keith J. Odegard, MD Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 12855 North Forty Drive, Suite 125, St. Louis, MO 63141 Phone: 314-966-0111 Fax: 314-966-1023 | |
Husam T Nawas, M.D. Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 12855 North Forty Drive, Suite 125, North Tower, St. Louis, MO 63141 Phone: 314-966-0111 Fax: 314-966-2810 | |
Mrs. Margaret Mary Rich, M.D. Orthopedic Surgery Medicare: Not Enrolled in Medicare Practice Location: 2001 South Lindbergh Boulevard, St. Louis, MO 63131 Phone: 314-432-3600 Fax: 314-872-7808 | |
Daemeon Achilles Nicolaou, MD Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 3635 Vista Ave, 7th Floor Desloge Towers, St. Louis, MO 63110 Phone: 314-577-8850 Fax: 314-268-5121 | |
William B. Strecker, M.D. Orthopedic Surgery Medicare: Not Enrolled in Medicare Practice Location: 1050 Old Des Peres Rd., Suite 100, St. Louis, MO 63131 Phone: 314-569-0612 Fax: 314-966-0664 | |
David D Greenberg, MD Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 3635 Vista Ave, St. Louis University, 7th Floor Desloge Towers, Dept Of Orthopaedic Surgery, St. Louis, MO 63110 Phone: 314-577-8850 Fax: 314-268-5121 |